Did you know?

CTLT Earnings Date and Information. Catalent last released its earnings data on November 15th, 2023. The reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.04. The business had revenue of $982 million for the quarter, compared to the consensus estimate of $939.62 million. Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first quarter of 2024. Net revenue was $982 million in the first quarter, which is down 4% as reported, and 6% in constant currency from Q1 2023Overall organic net revenue …NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key...SOMERSET, N.J. and NEW YORK, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for ...Catalent, Inc. (NYSE:CTLT) is not on our list of 30 Most Popular Stocks Among Hedge Funds.As per our database, 37 hedge fund portfolios held Catalent, Inc. (NYSE:CTLT) at the end of the third ...Catalent Inc CTLT Morningstar Rating Unlock Stock XNYS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance...Catalent ( NYSE: CTLT) is scheduled to announce Q1 earnings results on Wednesday, November 15th, before market open. The consensus EPS Estimate is -$0.13 (-112.5% Y/Y) and the consensus Revenue ...What: After Catalent (CTLT 0.70%) reported fiscal third-quarter earnings results that were shy of industry watchers' forecasts, its shares were trading down 13.6% at 3:45 p.m. ET today. So what ...Catalent (NYSE:CTLT) initiated with Hold rating at Deutsche Bank. Charles River Laboratories (NYSE: CRL ) initiated with Buy rating and $190 (22% upside) price target at Deutsche Bank.Investor Expectations to Drive Momentum within Cognizant Technology Solutions, Public Service Enterprise Group, Iron Mountain, Catalent, QuinStreet, and Entravision Communications — Discovering ...Nov 29, 2023 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Catalent stock is Hold based on the current 1 sell rating, 6 hold ratings and 5 buy ratings for CTLT. The average twelve-month price prediction for Catalent is $50.45 with a high price target of $62.00 and a low price target of $42.00. Nov 29, 2023 · Nov. 15. MT. Catalent beats quarterly revenue estimates. Nov. 15. RE. Earnings Flash (CTLT) CATALENT Posts Q1 Prelim Revenue $982M, vs. Street Est of $939.6M. Nov. 15. MT. Catalent, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023. NEW YORK, April 10, 2023 /PRNewswire/ -- Attention Catalent, Inc. ("Catalent") (NYSE: CTLT) shareholders:. The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on ...Nov 20, 2023 · Catalent (NYSE:CTLT – Free Report) had its target price trimmed by Wells Fargo & Company from $50.00 to $42.00 in a research report report published on Thursday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock. Other analysts have also recently issued reports about the company. Deutsche Bank Aktiengesellschaft increased […] When is Catalent (NYSE:CTLT) reporting earnings? A. Catalent ( CTLT6 Jan 2020 ... John Chiminski, Chair & CEO, Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle ... According to a recent report by Bloomberg Ratings, Catal NEW YORK, March 6, 2023 /PRNewswire/ -- Attention Catalent, Inc. ("Catalent") (NYSE: CTLT) shareholders:. The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on ... About Catalent Catalent, Inc. (NYSE: CTLT), an S&P 500®

18 Apr 2023 ... Aptus Capital Advisors' Dave Wagner joins 'Power Lunch' to discuss how to trade three stocks making headlines today: Johnson & Johnson, ...Catalent Inc (CTLT) Faces Headwinds in Q1 Fiscal 2024 Despite Reaffirming Full-Year Outlook Nov. 15, 2023 at 8:49 a.m. ET on GuruFocus.com Catalent (NYSE:CTLT) Gains …Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality ...Oct 31, 2023 · Catalent ( NYSE:CTLT) shares plunged nearly 18% in the morning session today after the healthcare major announced that it would release its preliminary first-quarter numbers on November 15. The ... NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest...

Nov 15, 2023 · Catalent, Inc. (NYSE:CTLT) is a global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and supply. Learn about its financials, news, presentations, and events on its investor relations website. Catalent ( NYSE:CTLT – Get Free Report) was upgraded by StockNews.com to a “sell” rating in a note issued to investors on Friday. A number of other equities research analysts have also ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Catalent, Inc. (NYSE:CTLT) is one of several pharmaceutical co. Possible cause: Real time Catalent (CTLT) stock price quote, stock graph, news & analysis. A.